Cargando…
COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies
Autores principales: | Martinez Lopez, Joaquin, De La Cruz, Javier, Gil-Manso, Rodrigo, Benavente Cuesta, Celina, Benito, Lauren, Hernandez, jose Angel, Herraez, Maria Regina, Herrera Puente, Pilar, Kwon, Mi, Quiroz, Keina, Arroyo, Andres, Alegre, Adrian, Llamas Sillero, María Pilar, López Jiménez, Javier, Sanchez-Godoy, Pedro, Duarte, Rafael F., Diez Martin, Jose L., Jiménez-Yuste, Víctor, Garcia-Suarez, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665213/ http://dx.doi.org/10.1182/blood-2022-169545 |
Ejemplares similares
-
Acute and Post-Acute COVID-19 Severity and Mortality in Patients with Hematologic Malignancies: A Population-Based Registry Study
por: Martinez-Lopez, Joaquin, et al.
Publicado: (2021) -
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study
por: García-Suárez, Julio, et al.
Publicado: (2020) -
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study
por: Martínez-López, Joaquín, et al.
Publicado: (2023) -
Impact of Sars-Cov-2 Infection in Hematopoietic Transplant Patients: Experience from the Madrid Group
por: Bailén, Rebeca, et al.
Publicado: (2020) -
A Multidisciplinary Journey towards Bone Tissue Engineering
por: Pedrero, Sara G., et al.
Publicado: (2021)